fbpx
Coronavirus

Pfizer and BioNTech Seek the FDA’s Approval for a Third COVID-19 Vaccine Dose

Pfizer and BioNTech announced on Wednesday that they have begun the process to seek approval from the Food and Drug Administration (FDA) for a third dose of their coronavirus vaccine.

In a statement, the companies said they plan to seek the approval for a third dose of Comirnaty to prevent COVID-19 in individuals aged 16 years and older. They intend to complete their submission by the end of this week.

Earlier this month, the Centers for Disease Control and Prevention (CDC) cleared a third vaccine dose from Pfizer-BioNTech and Moderna for people with moderate to severely compromised immune systems.

Read the source article at The Hill

Leave a Review or Comment

Back to top button